12 insiders have filed at AMLX since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Morningside Venture Investments Ltd | 10% owner | 5.00M | 4.52% | ||
| Cohen Joshua B | Co-Chief Executive Officer | 3.58M | 3.241% | 14 sells $3.4M | |
| Klee Justin B. | Co-Chief Executive Officer | 3.58M | 3.241% | 14 sells $3.4M | |
| Milne George M JR | Director | 812.9k | 0.735% | 1 buys $220k | |
| Olinger Margaret | Chief Commercial Officer | 276.1k | 0.25% | ||
| Frates James M | Chief Financial Officer | 272.7k | 0.247% | 1 buys $101k | 7 sells $474k |
| Bedrosian Camille L | Chief Medical Officer | 265.3k | 0.24% | 6 sells $474k | |
| Mazzariello Gina | Chief Legal Officer | 209.1k | 0.189% | 15 sells $894k | |
| Yeramian Patrick D | Chief Medical Officer | 205.6k | 0.186% | 1 sells $46k | |
| Firestone Karen | Director | 63.1k | 0.057% | 3 buys $267k | |
| Zeiher Bernhardt G | Director | 10.0k | <0.01% | 1 buys $37k | |
| Quimi Daphne | Director | 5.0k | <0.01% | 2 buys $9k |
Full register at boothcheck.com/insiders/AMLX. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.